Erik Engelson - Jun 16, 2022 Form 4 Insider Report for Lucira Health, Inc. (LHDXQ)

Role
President and Chief Executive, Director
Signature
/s/ Dan George, Attorney-in-Fact for Erik T. Engelson
Stock symbol
LHDXQ
Transactions as of
Jun 16, 2022
Transactions value $
$14,900
Form type
4
Date filed
6/17/2022, 06:45 PM
Previous filing
Mar 16, 2022
Next filing
Sep 19, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LHDXQ Common Stock Purchase $14.9K +10K +18.77% $1.49* 63.3K Jun 16, 2022 Direct F1
holding LHDXQ Common Stock 46.4K Jun 16, 2022 See footnote F2
holding LHDXQ Common Stock 192K Jun 16, 2022 See footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.45 to $1.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F2 The shares are held by the Elisabeth North Kuechler Engelson Trust, dated January 17, 2001, for which Mr. Engelson serves as trustee.
F3 The shares are held by Epic Pacific, LLC, of which Mr. Engelson is a Member. Mr. Engelson disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.